版本:
中国

BRIEF-Matinas Biopharma on track to report interim phase 2 data of MAT2203 in June 2017

April 3 Matinas Biopharma Holdings Inc:

* Matinas Biopharma reports 2016 financial results and provides corporate update

* Matinas Biopharma Holdings Inc - on track to report interim phase 2 data of MAT2203 and topline data of MAT2203 VVC study in June 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐